Yasheen Zhou

2.2k citations

25 papers · 1.1k indexed · h-index 15

Co-authors: Michael T. Flavin Liming Zhou Yuh‐Meei Lin Fa‐Ching Chen Jacob J. Plattner Yvonne R. Freund M.R. Alley Fernando Rock
Topics: Cancer therapeutics and mechanisms (7 papers)Fungal Plant Pathogen Control (4 papers)Organoboron and organosilicon chemistry (4 papers)
Cited by: Organic Chemistry Toxicology Pharmacology
Journals: Nature Communications FEBS Letters Antimicrobial Agents and Chemotherapy
Partner nations: United States China Spain

In The Last Decade

Yasheen Zhou

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by Yasheen Zhou

Since Specialization

Citations

This map shows the geographic impact of Yasheen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasheen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasheen Zhou more than expected).

Fields of papers citing papers by Yasheen Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasheen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasheen Zhou. The network helps show where Yasheen Zhou may publish in the future.

Co-authorship network of co-authors of Yasheen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yasheen Zhou. A scholar is included among the top collaborators of Yasheen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasheen Zhou. Yasheen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibiting C-4 Methyl Sterol Oxidase with Novel Diazaborines to Target Fungal Plant Pathogens 2022 ·ACS Chemical Biology ·Sang Hu Kim,(unknown),Yong-Kang Zhang,(unknown),(unknown),Yasheen Zhou,Chunliang Liu,Yan Cai,Haibo Zhou,Xuefei Chen,Emily Puumala,Dustin Duncan,Gerard D. Wright,(unknown),Luke Whitesell,Leah E. Cowen	8
2	Exploring boron applications in modern agriculture: A structure-activity relationship study of a novel series of multi-substitution benzoxaboroles for identification of potential fungicides 2021 ·Bioorganic & Medicinal Chemistry Letters ·Chunliang Liu,(unknown),(unknown),(unknown),Timothy P. Pastoor,Yasheen Zhou,(unknown),Yan Cai,Haibo Zhou,(unknown),Jiangong Wang,Sang Hu Kim,Luke Whitesell,Leah E. Cowen,Yongkang Zhang	6
3	A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue 2017 ·Nature Communications ·(unknown),Caroline L. Ng,Lee M,(unknown),(unknown),Yasheen Zhou,M.R. Alley,Vida Ahyong,Laura M. Sanz,María José Lafuente-Monasterio,(unknown),Patrick G. Schupp,Jiří Gut,Jenny Legac,Roland A. Cooper,Francisco‐Javier Gamo,Joseph L. DeRisi,Yvonne R. Freund,David A. Fidock,Philip J. Rosenthal	102
4	The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis 2017 ·Tuberculosis ·Aaron Korkegian,Theresa O’Malley,Yi Xia,Yasheen Zhou,David S. Carter,(unknown),(unknown),Dean A. Thompson,Thomas R. Ioerger,J.C. Sacchettini,(unknown),Tanya Parish	24
5	Optimization of isoxazoline amide benzoxaboroles for identification of a development candidate as an oral long acting animal ectoparasiticide 2016 ·Bioorganic & Medicinal Chemistry Letters ·Yong-Kang Zhang,Jacob J. Plattner,Eric E. Easom,Tsutomu Akama,Yasheen Zhou,W. Hunter White,Jean Defauw,(unknown),(unknown),Jianxin Cao,(unknown),(unknown)	19
6	Linking Phenotype to Kinase: Identification of a Novel Benzoxaborole Hinge-Binding Motif for Kinase Inhibition and Development of High-Potency Rho Kinase Inhibitors 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Tsutomu Akama,Chen Dong,(unknown),David Sullivan,Yasheen Zhou,Yongkang Zhang,Fernando Rock,Yvonne R. Freund,Liang Liu,Wei Bu,Anne Wu,Xiaoqing Fan,Kurt Jarnagin	44
7	Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents 2012 ·Anti-Cancer Agents in Medicinal Chemistry ·David E. Zembower,(unknown),(unknown),Mary J. Kuffel,Matthew M. Ames,Yasheen Zhou,Rama K. Mishra,(unknown),Michael T. Flavin,(unknown)	8
8	Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease 2012 ·Bioorganic & Medicinal Chemistry Letters ·Maosheng Duan,Wieslaw M. Kazmierski,Renae M. Crosby,Margaret Gartland,(unknown),(unknown),Amy Wang,Robert Hamatake,Lois L. Wright,Min Wu,Yong-Kang Zhang,Charles Z. Ding,Xianfeng Li,Yang Liu,Suoming Zhang,Yasheen Zhou,Jacob J. Plattner,Stephen J. Baker	1
9	Synthesis and antibacterial evaluation of a novel tricyclic oxaborole-fused fluoroquinolone 2012 ·Bioorganic & Medicinal Chemistry Letters ·Xianfeng Li,Yongkang Zhang,Jacob J. Plattner,Weimin Mao,M.R. Alley,Yi Xia,Vincent Hernandez,Yasheen Zhou,Charles Z. Ding,Jinpeng Li,(unknown),Hongwei Zhang,(unknown)	28
10	Boron‐based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center 2012 ·FEBS Letters ·Yvonne R. Freund,Tsutomu Akama,M.R. Alley,Joana Antunes,Chen Dong,Kurt Jarnagin,Richard H. Kimura,James A. Nieman,Kirk R. Maples,Jacob J. Plattner,Fernando Rock,Rashmi Sharma,Rajeshwar Singh,Virginia Sanders,Yasheen Zhou	89
11	Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Yi Xia,(unknown),Yasheen Zhou,M.R. Alley,Fernando Rock,Manisha Mohan,Maliwan Meewan,Stephen J. Baker,(unknown),Charles Z. Ding,(unknown),(unknown),Jacob J. Plattner	65
12	Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles 2011 ·Bioorganic & Medicinal Chemistry Letters ·Yong-Kang Zhang,Jacob J. Plattner,Yvonne R. Freund,Eric E. Easom,Yasheen Zhou,Long Ye,Huchen Zhou,David Waterson,Francisco‐Javier Gamo,Laura M. Sanz,Min Ge,Zhiya Li,Lingchao Li,Hailong Wang,Han Cui	43
13	Synthesis and structure–activity relationships of novel benzoxaboroles as a new class of antimalarial agents 2010 ·Bioorganic & Medicinal Chemistry Letters ·Yong-Kang Zhang,Jacob J. Plattner,Yvonne R. Freund,Eric E. Easom,Yasheen Zhou,Jiří Gut,Philip J. Rosenthal,David Waterson,Francisco‐Javier Gamo,Íñigo Angulo‐Barturen,Min Ge,Zhiya Li,Lingchao Li,(unknown),Han Cui,Hailong Wang,(unknown)	62
14	3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Christopher M. McBride,Paul A. Renhowe,Thomas G. Gesner,Johanna M. Jansen,Julie Qiaojin Lin,Sylvia Ma,Yasheen Zhou,Cynthia M. Shafer	16
15	Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies 2006 ·Bioorganic & Medicinal Chemistry Letters ·Xiaodong Lin,Jeremy Murray,(unknown),Michael Wang,Daniel T. W. Chu,Yasheen Zhou,(unknown),Susan Kaufman,Sylvia Ma,Eric Fang,Kenneth Crawford,Anne B. Jefferson	30
16	4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Zhi‐Jie Ni,Paul A. Barsanti,(unknown),(unknown),Daniel J. Poon,Simon S.M. Ng,Sabina Pecchi,Keith Pfister,Paul A. Renhowe,Savithri Ramurthy,Allan S. Wagman,Dirksen E. Bussiere,Vincent Le,Yasheen Zhou,Johanna M. Jansen,Sylvia Ma,Thomas G. Gesner	58
17	Chalcones and flavonoids as anti-Tuberculosis agents 2002 ·Bioorganic & Medicinal Chemistry ·Yuh‐Meei Lin,Yasheen Zhou,Michael T. Flavin,Liming Zhou,(unknown),Fa‐Ching Chen	411
18	Amyloid fibril formation in microwell plates for screening of inhibitors 2001 ·Amyloid ·(unknown),Rosemarie Raffen,Yasheen Zhou,Constance S. Cassidy,Michael T. Flavin,(unknown)	10
19	Comparative molecular modeling analysis of5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa 1999 ·Journal of Molecular Recognition ·Yasheen Zhou,Michael E. Johnson	8
20	Isolation, stereochemical assignments and molecular mechanics calculation of ethyl β-l-arabinopyranoside 1998 ·Carbohydrate Research ·Sheng‐Xiang Qiu,(unknown),Yasheen Zhou,(unknown),Norman R. Farnsworth,Michael E. Johnson,Harry H. S. Fong	3

About Yasheen Zhou

Yasheen Zhou is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Fungal Plant Pathogen Control (4 papers) and Organoboron and organosilicon chemistry (4 papers). The work is most often cited by research in Organic Chemistry (623 citations), Toxicology (57 citations) and Pharmacology (122 citations). Yasheen Zhou has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Michael T. Flavin, Liming Zhou, Yuh‐Meei Lin, Fa‐Ching Chen, Jacob J. Plattner, Yvonne R. Freund, M.R. Alley, Fernando Rock, Tsutomu Akama and Francisco‐Javier Gamo. Their work appears in journals such as Nature Communications, FEBS Letters and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact